Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment: More Relevant Than We Think. | JACC Adv;2(8): 100603, 2023 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment: More Relevant Than We Think.

Addison, Daniel; Shaaban, Adnan; Habib, Alma.

Affiliation

Addison D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
Shaaban A; Division of Cancer Prevention and Control, The Ohio State University, Columbus, Ohio, USA.
Habib A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.

JACC Adv ; 2(8): 100603, 2023 Oct.

Article in En | MEDLINE | ID: mdl-38938353

Key words

BTK inhibitors; atrial fibrillation; cardio-oncology; cardiotoxicity; ibrutinib

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Adv Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Adv Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States